ADVERSE-EFFECTS OF THERAPY FOR THE CORRECTION OF ANEMIA IN HEMODIALYSIS-PATIENTS

被引：0
作者：
WATSON, AJ [1 ]
机构：
[1] JOHNS HOPKINS UNIV, SCH MED, DIV NEPHROL, BALTIMORE, MD 21205 USA
来源：
SEMINARS IN NEPHROLOGY | 1989年 / 9卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：30 / 34
页数：5
相关论文
共 37 条
[1]   SERUM ALANINE AMINOTRANSFERASE OF DONORS IN RELATION TO THE RISK OF NON-A,NON-B HEPATITIS IN RECIPIENTS - THE TRANSFUSION-TRANSMITTED VIRUSES STUDY [J].
AACH, RD ;
SZMUNESS, W ;
MOSLEY, JW ;
HOLLINGER, FB ;
KAHN, RA ;
STEVENS, CE ;
EDWARDS, VM ;
WERCH, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1981, 304 (17) :989-994
[2]  
ACQUOT CJ, 1987, LANCET, V2, P1083
[3]  
AHMAD R, 1987, NEW ENGL J MED, V317, P169
[4]   IMMUNE-RESPONSE TO CHRONIC RED-BLOOD-CELL TRANSFUSION [J].
BLUMBERG, N ;
PECK, K ;
ROSS, K ;
AVILA, E .
VOX SANGUINIS, 1983, 44 (04) :212-217
[5]  
BOMMER J, 1987, Nephrology Dialysis Transplantation, V2, P238
[6]   EFFECT OF NANDROLONE DECANOATE ON ANEMIA OF CHRONIC-HEMODIALYSIS PATIENTS [J].
BUCHWALD, D ;
ARGYRES, S ;
EASTERLING, RE ;
OELSHLEGEL, FJ ;
BREWER, GJ ;
SCHOOMAKER, EB ;
ABBRECHT, PH ;
WILLIAMS, GW ;
WELLER, JM .
NEPHRON, 1977, 18 (04) :232-238
[7]   BENEFITS AND RISKS OF PROTRACTED TREATMENT WITH HUMAN RECOMBINANT ERYTHROPOIETIN IN PATIENTS HAVING HEMODIALYSIS [J].
CASATI, S ;
PASSERINI, P ;
CAMPISE, MR ;
GRAZIANI, G ;
CESANA, B ;
PERISIC, M ;
PONTICELLI, C .
BMJ-BRITISH MEDICAL JOURNAL, 1987, 295 (6605) :1017-1020
[8]  
CIAVARELLA D, 1988, NEW ENGL J MED, V318, P184
[9]   RESPONSE OF UREMIC PATIENTS TO NANDROLONE DECANOATE [J].
DOANE, BD ;
FRIED, W ;
SCHWARTZ, F .
ARCHIVES OF INTERNAL MEDICINE, 1975, 135 (07) :972-975
[10]   RED-CELL ALLOIMMUNIZATION IN CHRONIC RENAL-FAILURE PATIENTS UNDERGOING HEMODIALYSIS [J].
DOMEN, RE ;
RAMIREZ, G .
NEPHRON, 1988, 48 (04) :284-285
1234